NewCardio Announces Master Services Agreement With Dedicated Phase I

... a license to use NewCardio's QTinno(TM) software solution in all TQT studies where fully automated readings ... "We are excited to add NewCardio's QTinno(TM) solution to our advanced Core ECG laboratory. By ... analytical technology is the industry's first solution for the reliable automated analysis of ECGs used ...

Clinical and Histopathological Results Using Pollogen's TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy

... regen(TM) device- the latest aesthetic solution powered by 3rd generation TriPollar(TM) ... technology is a safe and effective non-invasive solution for skin tightening and body reshaping. ... reduction. The painless, non-invasive solution offers an ideal alternative to surgery-averse ...

Clinical Trial Results of Pollogen's TriPollar(TM) Radio Frequency Technology published in the Journal of the European Academy of Dermatology and Venereology

... using the regen(TM) system, the newest aesthetic solution powered by 3rd generation TriPollar RF technology ... been waiting for- a pain free, safe and effective solution for body contouring. The latest study clearly ... advance RF technology bringing safe, effective solution to a new standard. Since the launch of Pollogen's ...

PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS

... study comparing efficacy and safety of an IsoCrom solution versus inhaled steroids was presented by ... were used for inhalation. The novel 6% DSCG solution may also offer new therapeutic perspectives due ... is an investigational proprietary aqueous solution of 6% DSCG with excipients already approved for ...

ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting

... titled "Bepotastine Besilate Ophthalmic solution 1.5% Reduces Ocular Itching Following Dosing in ... titled "Bepotastine Besilate Ophthalmic solution 1.5% Reduces Tearing at 8 Hours Following Dosing ... Anti-Histamine Bepotastine Besilate Ophthalmic solution in a Healthy Pediatric Population from Ten to ...

Studies Show Combination Laser Therapy Effective At Clearing Acne, Reducing Oil Production

... of certain laser therapies as a long-term solution for treating active acne. The key is to ... laser was used - to activate the ALA, which is a solution that penetrates into the oil glands and is ... will work for you or provide a long-term solution for your condition," said Dr. ....

Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI

... Clinical trial data for Perforomist(TM) solution presented at International CHEST Conference ... Perforomist(TM) (formoterol fumarate) Inhalation solution nebulized treatment provided prolonged ... of Chest Physicians (ACCP). Perforomist(TM) solution was approved in 2007 by the FDA for ...

Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution

... The enhanced 2.1 version of the TrialWorks solution has updated functionality for reporting, data ... is a critical component of an overall eClinical solution that is needed to maximize the productivity and ... Electronic Data Capture (EDC). The TrialWorks solution provides full visibility into clinical trial ...

7 Health Ventures Invests in Tulip Medical

... company that is developing the next generation solution for the worldwide overweight and obesity ... all existing treatments fall short of providing a solution for the ever growing population of the overweight ... has the potential of providing a very effective solution while being extremely safe and easy to use." ...

Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery

... product that is added to arthroscopic irrigation solution and is designed to improve postoperative knee ... receive either standard arthroscopic irrigation solution or the same solution with OMS103HP added to it. Patients were ...

Study Reveals Novel LCD Solution Provides Significant Benefits Versus Calcipotriol In Treatment Of Moderate Psoriasis

... of a novel topically applied LCD (coal tar) solution (Psorent(TM)) versus calcipotriol cream ... results of an interim analysis reveal the LCD solution is outperforming calcipotriol cream in achieving ... with the aesthetics and ease of use of the LCD solution is high, with nearly 90% of patients expressing ...

Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients

... and efficacy of formoterol fumarate inhalation solution (FFIS; Perforomist(TM), 20mcg/2mL) while ... recently published. Perforomist(TM) Inhalation solution is indicated for long-term, twice-daily ... demonstrated that Perforomist(TM) Inhalation solution has a rapid onset of significant ...

Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone

... (Formoterol Fumarate) Inhalation solution presented at International ATS Conference -- ... tiotropium alone. Perforomist(TM) Inhalation solution was approved in 2007 by the FDA for long-term, ... Indication Perforomist(TM) Inhalation solution is indicated for the long-term, twice- daily ...

Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session

... dose of immediate release morphine sulfate solution and no more desirable than ALO-01 taken whole. ... taken orally, immediate-release morphine sulfate solution (120 mg) and placebo capsules. Participants ... were significantly higher for morphine sulfate solution (89.5, 90.4 and 89.7, respectively, p less ...

RICE MEMORIAL HOSPITAL PHARMACY STAFF EXPERIENCES A 55% REDUCTION IN TIME SPENT MANAGING PATIENT-SPECIFIC MEDICATIONS USING OMNICELL SINGLEPOINTE SOLUTION

... "The implementation of the SinglePointe solution allowed us to evaluate our drug distribution ... indicated the installation of the SinglePointe solution resulted in a fifty-five percent reduction in ... "It is gratifying to see that the SinglePointe solution significantly improved pharmacy staff ...

ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)

... Poster # A593: Efficacy of Bromfenac Ophthalmic solution Administered Once Daily for Ocular Inflammation ... Phase III Clinical Trials of Bromfenac Ophthalmic solution Administered Once Daily for Cataract Surgery; ... Istalol(R) Istalol is a once-daily, topical solution of timolol, a beta-blocking agent for the ...

More Than 1.5 Million Americans Sickened, Injured or Killed by Medication Errors Each Year; Seniors Most at Risk

... DailyMed(TM) Launches Innovative solution to Medication Mismanagement ... of DailyMed, a revolutionary, first-to-market solution to problems caused by medication mismanagement. ... dispensing system, provides a safe, effective solution to the dangers of medication mismanagement-making ...

Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD

... on concomitant use of Perforomist(TM) Inhalation solution with tiotropium for COPD ... alone. For physicians, Perforomist(TM) Inhalation solution and commonly prescribed ... assessment of how Perforomist(TM) Inhalation solution may be used concomitantly with tiotropium for ...

Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007

... concomitant use of Perforomist(TM) Inhalation solution with tiotropium for the treatment of COPD. Perforomist(TM) Inhalation solution is the first and only FDA-approved nebulized form ... Solution. About Perforomist(TM) Inhalation solution Indication Perforomist(TM) ...

Innovative Psoriasis Treatment PSORENT(R) Announces Healthcare Cost Savings Potential Consistent with President Obama's Announcement on Healthcare Reform

... you, Mr. President." About PSORENT(R) PSORENT(R) is a new topical solution that has the proven efficacy of a prescription medication but is available as an OTC. This aesthetically advanced, quick-drying solution is highly effective, easy and pleasant to use, and has a patient ...

TriLink Launches CleanAmp(TM) dNTPs for Hot Start PCR

... - CleanAmp(TM) dNTPs. CleanAmp(TM) dNTPs offer a less expensive solution to improved hot start PCR results. Using CleanAmp(TM) dNTPs allows ... more general solution. Either product will provide a very cost effective solution when compared to the modified enzymes available on the market." ...

ePharmaSolutions' Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award

... panel of 14 expert judges. The ePharmaSolutions Clinical Trial Portal solution won in the Clinical Trials Management category. "We are absolutely ... application is recognized as the most innovative clinical trial management solution by such a distinguished panel of judges," stated Lance Converse, Founder ...

Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)

... UC San Diego and Raptor understand the need to deliver a treatment solution that augments disease management through diet and exercise and we are dedicated to working together to find a solution for these patients." About Raptor Pharmaceuticals Corp. ...

CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year

... the right tactics to engage each patient. The Adherence to Drug Therapy solution is a mail and retail based program designed to impact patient behavior ... prescription and their health care provider. The Adherence to Drug Therapy solution helps approximately 88% of heart failure patients maintain optimal ...

MGuard(TM) Coronary Stent System Approved in Israel

... symposium on December 8th at the ICI Meeting, MGuard(TM): A Unique solution for Managing Embolic Complications in Acute MI and SVG. Martin Leon MD and ... its products the industry standard for stents and to provide a superior solution to the key clinical issues of current stenting procedures: restenosis, ...

Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer

... to prescribing unnecessary therapy for others. Testing solution Currently, tumors are tested for HER2 with 2 main ... , ensuring highly reliable quality controls. MapQuant Dx(TM) solution is developed under the innovation support program of the French Health ...

Nuvo Research presents positive Phase III study results for Pennsaid at leading rheumatology conference

... and extend previous studies and show that this novel topical diclofenac solution is efficacious for the relief of symptoms in patients with symptomatic ... Patients in this five-arm, double-blind, 12-week trial applied a topical solution and took an oral pill. The five arms were: 1) Pennsaid(R) plus oral ...

New Study Offers More Than a Decade of Evidence for Minimally-Invasive Surgery to Treat Female Incontinence

... the evidence showing that the TVT procedure is a safe, effective solution that offers excellent long-term cure rates for women suffering with SUI," ... provides support only when needed and creates a "tension-free" treatment solution that reduces the risk of over-correcting. As with any suspension ...

Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program

... The VLP vaccine may be an effective and affordable component of a pandemic solution for countries that do not currently have in-border pandemic vaccine ... ready-to-use bioprocessing technologies, signals the promise of a solution to problems countries face in preparing for the inevitability of pandemic ...

Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines

... for longer than two weeks is not recommended. Refrigerated KALETRA oral solution remains stable until the expiration date printed on the label. If stored at room temperature up to 77 degrees F (25 degrees C), KALETRA oral solution should be used within two months. Avoid exposure to excessive heat. ...

Inspire's Phase 3 CF Trial, Using PARI's Nebulizer & Compressor, Shows Positive Top-Line Results

... top-line results and hope that Inspire's denufosol tetrasodium inhalation solution delivered via PARI's LC STAR and PRONEB Ultra compressor will become the ... 352-patient Phase 3 trial (TIGER-1) with denufosol tetrasodium inhalation solution for the treatment of cystic fibrosis. Additional information is available ...

JDSU WaveReady Receives Brocade Data Center Ready Status for Brocade-Based Storage Area Network (SAN) Infrastructures

... director and WaveReady business unit manager. "We are pleased to have our solution verified by Brocade, an industry leader in cutting-edge data networking ... services to over 175 Km. WaveReady offers a simple and reliable transport solution for data center connectivity, remote back-up and disaster and recovery ...

FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria

... now approved for use in adults and children 6 years and older. "The oral solution of XYZAL(R) provides a welcome alternative for those patients who have ... of Tennessee Health Science Center in Memphis, Tennessee. "Both the oral solution and tablets offer patients powerful and long-lasting allergy relief." ...

First Clinical Volumetric Modulated Arc Therapy Treatment Completed With Elekta Synergy(R) S at General Hospital Vienna

... next generation linear accelerator control software. Elekta's VMAT solution also includes ERGO++ treatment planning system for rotational therapy, and ... oncology Electronic Medical Records (EMR) system. This complete VMAT solution is now available in upgrades to existing Elekta accelerators. General ...

Independent Clinical Results Confirm Up to a 7-Centimeter Reduction in Body Circumference Using UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring System

... from February 10-13. UltraShape is the clinically proven non-invasive solution for fat reduction and body contouring using "non- thermal" selective ... and clinically proven non-invasive fat reduction and body contouring solution for both men and women. The device produces mechanical, non-thermal, ...

Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway

... of molecular diagnostics. Our goal is that our simplified, automated solution will allow these time-consuming, complex, and labor-intensive tests to ... together molecular diagnostic expertise at NUI Galway with automated solution expertise at Beckman Coulter that will result in the development of ...

Keppra XR(TM) Extended-Release Tablets Filed with the FDA

... all seizures. Important Safety Information Keppra(R) tablets and oral solution are indicated as adjunctive therapy in the treatment of partial onset ... is temporarily not feasible. Keppra(R) tablets and oral solution are associated with the occurrence of central nervous system adverse ...

UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets

... all seizures. Important Safety Information Keppra(R) tablets and oral solution are indicated as adjunctive therapy in the treatment of partial onset ... is temporarily not feasible. Keppra(R) tablets and oral solution are associated with the occurrence of central nervous system adverse ...

Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio

... MAMMOMAT Novation S Introducing MAMMOMAT(R) Novation S, a cost-effective solution for facilities that are making the transition to digital breast imaging ... found on standard MRI exams without missing any cancers++. Siemens' solution for quantitative breast MRI breast spectroscopy, syngo(R) GRACE, allows ...

ISTA Pharmaceuticals Presents Results from Two Phase III Clinical Trials of Xibrom(TM) QD (Once-daily) Formulation at the American Academy of Ophthalmology Annual Meeting

... of Xibrom was as effective as both diclofenac sodium 0.1% ophthalmic solution or ketorolac tromethamine 0.5% ophthalmic solution, each dosed four times ... from 2 Phase III Clinical Trials of a Once Daily Bromfenac Ophthalmic solution for Ocular Surgery Contributing authors: William B. Trattler, MD; Peter ....